Literature DB >> 27094382

Squeezing observational data for better causal inference: Methods and examples for prevention research.

Diego Garcia-Huidobro1,2,3, J Michael Oakes4.   

Abstract

Randomised controlled trials (RCTs) are typically viewed as the gold standard for causal inference. This is because effects of interest can be identified with the fewest assumptions, especially imbalance in background characteristics. Yet because conducting RCTs are expensive, time consuming and sometimes unethical, observational studies are frequently used to study causal associations. In these studies, imbalance, or confounding, is usually controlled with multiple regression, which entails strong assumptions. The purpose of this manuscript is to describe strengths and weaknesses of several methods to control for confounding in observational studies, and to demonstrate their use in cross-sectional dataset that use patient registration data from the Juan Pablo II Primary Care Clinic in La Pintana-Chile. The dataset contains responses from 5855 families who provided complete information on family socio-demographics, family functioning and health problems among their family members. We employ regression adjustment, stratification, restriction, matching, propensity score matching, standardisation and inverse probability weighting to illustrate the approaches to better causal inference in non-experimental data and compare results. By applying study design and data analysis techniques that control for confounding in different ways than regression adjustment, researchers may strengthen the scientific relevance of observational studies.
© 2016 International Union of Psychological Science.

Entities:  

Keywords:  Causal inference; Methodology; Methods; Observational studies; Randomised trials

Mesh:

Year:  2016        PMID: 27094382      PMCID: PMC5549466          DOI: 10.1002/ijop.12275

Source DB:  PubMed          Journal:  Int J Psychol        ISSN: 0020-7594


  5 in total

1.  Evidence-based public health: moving beyond randomized trials.

Authors:  Cesar G Victora; Jean-Pierre Habicht; Jennifer Bryce
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  The consistency statement in causal inference: a definition or an assumption?

Authors:  Stephen R Cole; Constantine E Frangakis
Journal:  Epidemiology       Date:  2009-01       Impact factor: 4.822

3.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

4.  Family functioning style and health: opportunities for health prevention in primary care.

Authors:  Diego García-Huidobro; Klaus Puschel; Gabriela Soto
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

5.  Effect identification in comparative effectiveness research.

Authors:  J Michael Oakes
Journal:  EGEMS (Wash DC)       Date:  2013-01-17
  5 in total
  3 in total

1.  Adaptive Recruitment and Parenting Interventions for Immigrant Latino Families with Adolescents.

Authors:  Diego Garcia-Huidobro; Maria O Diaspro-Higuera; Dora Palma; Roberto Palma; Luis Ortega; Rebecca Shlafer; Elizabeth Wieling; Timothy Piehler; Gerald August; Maria V Svetaz; Iris W Borowsky; Michele L Allen
Journal:  Prev Sci       Date:  2019-01

2.  Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method.

Authors:  Amy Rogers; Gillian Craig; Angela Flynn; Isla Mackenzie; Thomas MacDonald; Alexander Doney
Journal:  Trials       Date:  2020-06-05       Impact factor: 2.279

3.  Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension.

Authors:  Amy Rogers; Angela Flynn; Isla S Mackenzie; Lewis McConnachie; Rebecca Barr; Robert W V Flynn; Steve Morant; Thomas M MacDonald; Alexander Doney
Journal:  Trials       Date:  2021-11-17       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.